One Health is a multi-sectoral approach that aims to balance and optimise the health of people, animals, plants, and their shared environment, recognising their interconnection.
From 23–26 April 2024, experts from the European Centre for Disease Prevention and Control (ECDC) and the African Centres for Disease Control and Prevention (Africa CDC) met in Stockholm, Sweden, to exchange expertise on surveillance, data management and epidemic intelligence.
This report describes the external quality assessment (EQA) scheme for the European Legionnaires’ disease Surveillance network, for the detection, isolation, identification, and enumeration of Legionella species.
A prolonged genomic cluster of 20 human Listeria monocytogenes ST1607 infections has been reported. The most recent case was reported in March 2024 in Denmark.
This report collects all COVID-19 long-term care facilities (LTCF) data reported to ECDC from 2021 and concludes the EU/EEA LTCF COVID-19 specific surveillance data collection from 2021-2023.
This is a summary of the fourth joint inter-agency report on integrated analysis of antimicrobial consumption and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals in the European Union (JIACRA IV – 2019–2021).
This report provides an integrated analysis of relationships between antimicrobial consumption in humans and food- producing animals and the occurrence of antimicrobial resistance in bacteria from humans and food- producing animals, respectively.
This special episode is hosted by James Ramsey, Head of the Communication Unit at the European Food Safety Authority (EFSA). He is joined by experts from ECDC, EFSA, the European Medicines Agency (EMA), the European Environment Agency (EEA), and the European Chemicals Agency (ECHA) to discuss the One Health perspective.
This core protocol for ECDC studies of VE against hospitalisation with SARI laboratory-confirmed with SARS-CoV-2 or with influenza, version 3.0, represents an update to the main elements for a multi-country hospital-based study of COVID-19 vaccine effectiveness in patients hospitalised with SARI, initially published as version 1.0 [5], updated to version 2.0 [6].
From 29 January to 2 February 2024, a team of experts from EC, ECDC, EFSA, Epiconcept and the Integrated Quality Laboratory Services (IQLS) will visit North Macedonia.